Advertisement
BD Biosciences
BD Biosciences

The Scientist

» patent

Most Recent

image: “Heroes of CRISPR” Disputed

“Heroes of CRISPR” Disputed

By | January 19, 2016

Critics have harsh words for the Broad Institute’s Eric Lander and Cell over a recent perspective piece describing the history of CRISPR.

10 Comments

image: Who Owns CRISPR, Cont’d

Who Owns CRISPR, Cont’d

By | January 14, 2016

The US Patent and Trademark Office declares a patent “interference” and will seek to determine who has rights to the gene-editing technology.

1 Comment

image: TS Picks: CRISPR Patent Edition

TS Picks: CRISPR Patent Edition

By | January 5, 2016

A challenge to the first CRISPR patent just got teeth.

3 Comments

image: Who Owns CRISPR?

Who Owns CRISPR?

By | April 3, 2015

With one US patent awarded and many other applications under consideration for the popular genome-editing technology, companies are adopting multiple strategies to navigate the complex intellectual property landscape.

6 Comments

American universities top a list of educational institutions ranked according to their number of international patent applications.

0 Comments

image: Myriad Settles Suit

Myriad Settles Suit

By | January 26, 2015

The Utah-based firm has settled its lawsuit claiming patent infringement against Pathway Genomics.

0 Comments

image: Merck Buys Cubist for $8.4B

Merck Buys Cubist for $8.4B

By | December 11, 2014

Hours after the pharmaceutical giant announced the acquisition, a federal judge invalidated key patents behind the antibiotic maker’s most lucrative product.

0 Comments

image: Keeping Up with IP

Keeping Up with IP

By | September 1, 2014

It’s never too early to start thinking about intellectual property rights—even for biologists doing basic research.

0 Comments

image: Patent Plea Ping Pong

Patent Plea Ping Pong

By | August 21, 2014

A genetic testing firm accused of infringing upon Myriad Genetics’s gene patents fights back in an attempt to wipe other patents out.

1 Comment

image: Yet Another Lawsuit over Genetic Tests

Yet Another Lawsuit over Genetic Tests

By | June 17, 2014

Myriad Genetics, the company originally behind tests for the cancer-associated BRCA mutations, is suing another competitor for patent infringement.

0 Comments

Advertisement

Popular Now

  1. The Mycobiome
    Features The Mycobiome

    The largely overlooked resident fungal community plays a critical role in human health and disease.

  2. Antibody Alternatives
    Features Antibody Alternatives

    Nucleic acid aptamers and protein scaffolds could change the way researchers study biological processes and treat disease.

  3. Holding Their Ground
    Features Holding Their Ground

    To protect the global food supply, scientists want to understand—and enhance—plants’ natural resistance to pathogens.

  4. Circadian Clock and Aging
    Daily News Circadian Clock and Aging

    Whether a critical circadian clock gene is deleted before or after birth impacts the observed aging-related effects in mice.

Advertisement
Advertisement
Life Technologies